Meeting a critical need to help prevent hypoglycemia in patients with diabetes

Zucara Therapeutics Inc., a spin-off company by The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is advancing a novel technology that is showing promise as a long-term therapeutic approach to prevent hypoglycemia in people with diabetes who are insulin-dependent.